Correlation Between Inhibrx and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Denali Therapeutics, you can compare the effects of market volatilities on Inhibrx and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Denali Therapeutics.
Diversification Opportunities for Inhibrx and Denali Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibrx and Denali is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Denali Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 0.86 times more return on investment than Denali Therapeutics. However, Inhibrx is 1.16 times less risky than Denali Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Denali Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Denali Therapeutics |
Inhibrx and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Denali Therapeutics
The main advantage of trading using opposite Inhibrx and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Denali Therapeutics vs. Tff Pharmaceuticals | Denali Therapeutics vs. Eliem Therapeutics | Denali Therapeutics vs. Inhibrx | Denali Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |